Swedish Indian businessman Prashant Agarwal participates in the share issue as top underwriter
Scandinavian ChemoTech announces that Prashant Agarwal will participate as a top underwriter, with 500 000 SEK, which means he wishes to subscribe in the over-allotment option if the rights issue is fully subscribed.Prashant has a deep understanding of the healthcare needs in emerging markets and in Europe. He brings a significant network which can benefit ChemoTech’s development. Through his holding company Ajna Holding he has interests in Sports, Food Processing and Infrastructure (Engineering, Procurement and Construction), and among them a joint-venture with Serneke International AB,